期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 60, 期 5, 页码 1916-1927出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.6b01689
关键词
-
资金
- National Institutes of Health Research [R01-GM090323, R01-GM113363, R01-GM085006]
theta-Defensin RTD-1 is a noncompetitive inhibitor of anthrax lethal factor (LF) protease (IC50 = 390 +/- 20 nM, K-i = 365 +/- 20 nM) and a weak inhibitor of other mammalian metalloproteases such as TNF alpha converting enzyme (TACE) (K-i = 4.45 0.48 mu M). Using full sequence amino acid scanning in combination with a highly efficient one-pot cyclization-folding approach, we obtained an RTD-1-based peptide that was around 10 times more active than wild-type RTD-1 in inhibiting LF protease (IC50 = 43 +/- 3 nM, K-i = 18 +/- 1 nM). The most active peptide was completely symmetrical, rich in Arg and Trp residues, and able to adopt a native RTD-1-like structure. These results show the power of optimized chemical peptide synthesis approaches for the efficient production of libraries of disulfide-rich backbone-cyclized peptides to quickly perform structure activity relationship studies for optimizing protease inhibitors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据